<DOC>
	<DOCNO>NCT00711737</DOCNO>
	<brief_summary>The purpose study explore change metabolic parameter patient treat escitalopram six month major depression , generalize anxiety disorder panic disorder , without agoraphobia .</brief_summary>
	<brief_title>Study Changes Metabolic Parameters Patients Treated With Escitalopram Six Months</brief_title>
	<detailed_description>This open-label study , 4 schedule visit . Recruitment 100 subject . Assessments include demographic , diagnosis , smoke frequency , Clinical Global Scale ( CGI-S ) , weight , height , blood pressure , waist hip circumference fast blood glucose lipd profile . Statistical analysis exploratory mainly descriptive .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Anxiety Disorders</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Panic Disorder</mesh_term>
	<mesh_term>Citalopram</mesh_term>
	<mesh_term>Dexetimide</mesh_term>
	<criteria>Give informed consent Requires pharmacological treatment escitalopram major depression , generalize anxiety disorder panic disorder Aged 21 year old Able comprehend comply protocol Not pregnant childbearing age , use adequate method contraception Currently take take previous 3 month , antidepressant , antipsychotic , mood stabilizer , weight loss lipidprofile modify drug Contraindications escitalopram Unstable medical illness and/or already treatment diabetes , hypertension , dyslipidemia , ischemic heart disease History nonresponse escitalopram Meets IDF definition metabolic syndrome Significant risk suicide Primary diagnosis comorbid diagnosis psychotic disorder , bipolar disorder , substance dependence and/or dementia</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2011</verification_date>
	<keyword>metabolic parameter</keyword>
	<keyword>escitalopram</keyword>
	<keyword>metabolic syndrome</keyword>
	<keyword>antidepressant</keyword>
</DOC>